TY - JOUR
T1 - Burden and health care resource utilization in neovascular age-related macular degeneration
T2 - Findings of a multicountry study
AU - Soubrane, Gisèle
AU - Cruess, Alan
AU - Lotery, Andrew
AU - Pauleikhoff, Daniel
AU - Monès, Jordi
AU - Xu, Xiao
AU - Zlateva, Gergana
AU - Buggage, Ronald
AU - Conlon, John
AU - Goss, Thomas F.
PY - 2007/9
Y1 - 2007/9
N2 - Objective: To describe the burden of bilateral neovascular age-related macular degeneration (NV-AMD) on patient-reported functioning and health resource utilization. Methods: A cross-sectional study of 401 patients with bilateral NV-AMD and 471 elderly control subjects without AMD was conducted in 5 countries. Subjects completed a telephone survey, including the National Eye Institute 25-Item Visual Function Questionnaire, the EuroQol instrument, the Hospital Anxiety and Depression Scale, and history of falls, fractures, and health care resource utilization. Results: The mean age for patients with NV-AMD was 78.1 years, and 65% were women. The patients reported 45% worse vision-related functioning, 13% worse overall well-being, and 30% more anxiety and 42% more depression symptoms than controls after adjusting for covariates (all, P < .001). The effect of NV-AMD was also observed as a doubled fall rate (16% vs 8% [P < .001]) and a quadrupled need for assistance with daily activities (29% vs 7% [P < .001]) in the patients compared with controls. Conclusions: The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.
AB - Objective: To describe the burden of bilateral neovascular age-related macular degeneration (NV-AMD) on patient-reported functioning and health resource utilization. Methods: A cross-sectional study of 401 patients with bilateral NV-AMD and 471 elderly control subjects without AMD was conducted in 5 countries. Subjects completed a telephone survey, including the National Eye Institute 25-Item Visual Function Questionnaire, the EuroQol instrument, the Hospital Anxiety and Depression Scale, and history of falls, fractures, and health care resource utilization. Results: The mean age for patients with NV-AMD was 78.1 years, and 65% were women. The patients reported 45% worse vision-related functioning, 13% worse overall well-being, and 30% more anxiety and 42% more depression symptoms than controls after adjusting for covariates (all, P < .001). The effect of NV-AMD was also observed as a doubled fall rate (16% vs 8% [P < .001]) and a quadrupled need for assistance with daily activities (29% vs 7% [P < .001]) in the patients compared with controls. Conclusions: The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.
UR - http://www.scopus.com/inward/record.url?scp=34548604340&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548604340&partnerID=8YFLogxK
U2 - 10.1001/archopht.125.9.1249
DO - 10.1001/archopht.125.9.1249
M3 - Article
C2 - 17846366
AN - SCOPUS:34548604340
SN - 0003-9950
VL - 125
SP - 1249
EP - 1254
JO - Archives of Ophthalmology
JF - Archives of Ophthalmology
IS - 9
ER -